A decline in renal function at three months of treatment, which then improved back to baseline levels at one to two months after drug discontinuation, was reported
Individuals who may benefit include those experiencing fatigue associated with oxidative stress or inadequate cellular recovery, people with compromised liver function or high toxic exposure, those dealing with chronic inflammation or frequent illness, athletes seeking to support faster recovery from intense training, and individuals with age-related concerns where declining glutathione synthesis is a documented phenomenon
Keremi B, Lohinai Z, Komora P, Duhaj S, Borsi K, Jobbagy-Ovari G, et al
[16] [17] At therapeutic doses, Tesofensine also induces less stereotypy than other DA acting appetite suppressants